DrugDashboards
← Home
Manufacturing facility

ScieGen Pharmaceuticals, INC.

A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.

Country
United States
Registered address
89 Arkay Drive, Hauppauge, New York (NY) 11788-3727, United States (USA)
Operations here
analysislabelmanufacturepack
FDA identifiers
FEI 3008298016 · DUNS 079391286

FDA inspection history

Outcomes of closed FDA inspections at this site (drug and biologic program areas).

  • VAIDrug Quality Assurance2026-05-15
  • NAIBioresearch Monitoring2025-12-19
  • NAIDrug Quality Assurance2024-02-20
  • OAIBioresearch Monitoring2023-04-21
  • VAIDrug Quality Assurance2022-09-02
  • VAIDrug Quality Assurance2021-12-20
  • VAIDrug Quality Assurance2019-06-21
  • NAIDrug Quality Assurance2018-04-20
  • NAIDrug Quality Assurance2018-03-16
  • NAIBioresearch Monitoring2018-03-14
  • VAIBioresearch Monitoring2015-01-09
  • VAIDrug Quality Assurance2015-01-09
  • NAIDrug Quality Assurance2013-09-18
  • NAIDrug Quality Assurance2013-04-02
  • VAIDrug Quality Assurance2011-09-16

Drugs this plant is listed as making

61 distinct drugs across 312 products name this site in their FDA label.

Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.